Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Nanoparticle Delivered Human Biliverdin Reductase-Based Peptide Increases Glucose Uptake by Activating IRK/Akt/GSK3 Axis: The Peptide Is Effective in the Cell and Wild-Type and Diabetic Ob/Ob Mice.

Authors: Gibbs, Peter E M; Miralem, Tihomir; Lerner-Marmarosh, Nicole; Maines, Mahin D

Published In J Diabetes Res, (2016)

Abstract: Insulin's stimulation of glucose uptake by binding to the IRK extracellular domain is compromised in diabetes. We have recently described an unprecedented approach to stimulating glucose uptake. KYCCSRK (P2) peptide, corresponding to the C-terminal segment of hBVR, was effective in binding to and inducing conformational change in the IRK intracellular kinase domain. Although myristoylated P2, made of L-amino acids, was effective in cell culture, its use for animal studies was unsuitable. We developed a peptidase-resistant formulation of the peptide that was efficient in both mice and cell culture systems. The peptide was constructed of D-amino acids, in reverse order, and blocked at both termini. Delivery of the encapsulated peptide to HepG2 and HSKM cells was confirmed by its prolonged effect on stimulation of glucose uptake (>6 h). The peptide improved glucose clearance in both wild-type and Ob/Ob mice; it lowered blood glucose levels and suppressed glucose-stimulated insulin secretion. IRK activity was stimulated in the liver of treated mice and in cultured cells. The peptide potentiated function of IRK's downstream effector, Akt-GSK3-(α, β) axis. Thus, P2-based approach can be used for improving glucose uptake by cells. Also, it allows for screening peptides in vitro and in animal models for treatment of diabetes.

PubMed ID: 27294151 Exiting the NIEHS site

MeSH Terms: Animals; Blood Glucose/drug effects*; Blood Glucose/metabolism; Glucose; Glycogen Synthase Kinase 3/drug effects*; Glycogen Synthase Kinase 3/metabolism; HEK293 Cells; Humans; Mice; Mice, Obese; Nanoparticles; Oxidoreductases Acting on CH-CH Group Donors/pharmacology*; Peptide Fragments/pharmacology*; Proto-Oncogene Proteins c-akt/drug effects*; Proto-Oncogene Proteins c-akt/metabolism; Receptor, Insulin/drug effects*; Receptor, Insulin/metabolism

Back
to Top